Literature DB >> 16562569

The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy.

David C Isbell1, Christopher M Kramer.   

Abstract

Over the last several years, the role of cardiac magnetic resonance imaging in the diagnosis and management of heart failure has been rapidly expanding. The techniques unrivaled flexibility, accuracy in defining ventricular structure and function, and capacity to characterize tissue makes it particularly well suited for the study of the nonischemic cardiomyopathies. In this article, we provide an overview of the existing literature highlighting the diagnostic utility and prognostic power of cardiac magnetic resonance imaging in the nonischemic cardiomyopathies.

Entities:  

Mesh:

Year:  2006        PMID: 16562569     DOI: 10.1053/j.sult.2005.11.002

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  5 in total

1.  MRI of nonischemic cardiomyopathy.

Authors:  David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

2.  Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy?

Authors:  Atsushi K Kono; Kazunari Ishii; Hiroyuki Kumagai; Yasuyo Taniguchi; Teishi Kajiya; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2010-06-30       Impact factor: 2.374

Review 3.  Noninvasive imaging of the heart and coronary arteries.

Authors:  Amy M West; Christopher M Kramer
Journal:  Surg Clin North Am       Date:  2009-08       Impact factor: 2.741

Review 4.  Comprehensive cardiac magnetic resonance imaging.

Authors:  Amy M West; Christopher M Kramer
Journal:  J Invasive Cardiol       Date:  2009-07       Impact factor: 2.022

5.  Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability.

Authors:  M A G M Olimulder; M A Galjee; J van Es; L J Wagenaar; C von Birgelen
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.